ES546189A0 - Procedimiento de obtencion de derivados de 4-aril-1,4-dihi- dropiridinas - Google Patents
Procedimiento de obtencion de derivados de 4-aril-1,4-dihi- dropiridinasInfo
- Publication number
- ES546189A0 ES546189A0 ES546189A ES546189A ES546189A0 ES 546189 A0 ES546189 A0 ES 546189A0 ES 546189 A ES546189 A ES 546189A ES 546189 A ES546189 A ES 546189A ES 546189 A0 ES546189 A0 ES 546189A0
- Authority
- ES
- Spain
- Prior art keywords
- dropiridinas
- dihi
- aril
- procedure
- obtaining derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848421039A GB8421039D0 (en) | 1984-08-17 | 1984-08-17 | Heterocyclic compounds |
| GB858515751A GB8515751D0 (en) | 1985-06-21 | 1985-06-21 | Heterocyclic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8604564A1 ES8604564A1 (es) | 1986-02-01 |
| ES546189A0 true ES546189A0 (es) | 1986-02-01 |
Family
ID=26288137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES546189A Expired ES8604564A1 (es) | 1984-08-17 | 1985-08-16 | Procedimiento de obtencion de derivados de 4-aril-1,4-dihi- dropiridinas |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5068337A (es) |
| EP (1) | EP0172029B1 (es) |
| JP (1) | JPH0680053B2 (es) |
| KR (1) | KR930000167B1 (es) |
| AR (1) | AR241417A1 (es) |
| AT (1) | ATE61055T1 (es) |
| AU (1) | AU587388B2 (es) |
| CA (1) | CA1310011C (es) |
| CZ (1) | CZ279473B6 (es) |
| DE (1) | DE3581858D1 (es) |
| DK (1) | DK374185A (es) |
| ES (1) | ES8604564A1 (es) |
| FI (1) | FI89166C (es) |
| GB (1) | GB2168969B (es) |
| GR (1) | GR851819B (es) |
| HU (1) | HU194868B (es) |
| IE (1) | IE58706B1 (es) |
| IL (1) | IL75943A (es) |
| MY (1) | MY101736A (es) |
| NZ (1) | NZ212956A (es) |
| PH (1) | PH26049A (es) |
| PT (1) | PT80956B (es) |
| SU (1) | SU1486059A3 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1267416A (en) * | 1985-06-17 | 1990-04-03 | Ila Sircar | 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders |
| IT1204421B (it) * | 1986-06-27 | 1989-03-01 | Boehringer Biochemia Srl | 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono |
| EP0225175A3 (en) * | 1985-11-28 | 1988-12-28 | FISONS plc | Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof |
| GB8602518D0 (en) * | 1986-02-01 | 1986-03-05 | Wyeth John & Brother Ltd | 1 4-dihydropyridines |
| DE3617976A1 (de) * | 1986-05-28 | 1988-01-14 | Alter Sa | 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten |
| FR2602231B1 (fr) * | 1986-08-04 | 1988-10-28 | Adir | Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| JPH02501736A (ja) * | 1986-12-24 | 1990-06-14 | ベリンガー マンハイム イタリア エッセ ピ ア | 新規なアラルキル‐１，４‐ジヒドロピリジンおよびその製造法、ならびにそれを含有する製薬組成物 |
| GB8729471D0 (en) * | 1987-12-17 | 1988-02-03 | Wyeth John & Brother Ltd | New crystal form |
| JPH0286981A (ja) * | 1988-09-22 | 1990-03-27 | Aisin Seiki Co Ltd | ロータリ圧縮機 |
| US5616591A (en) * | 1992-03-27 | 1997-04-01 | E.R. Squibb & Sons, Inc. | Indole- and benzimidazole-substituted quinoline derivatives |
| DE4233601A1 (de) * | 1992-10-06 | 1994-04-07 | Bayer Ag | 3-substituierte Chinolin-5-carbonsäuren |
| US5981252A (en) * | 1993-06-25 | 1999-11-09 | Smithkline Beecham | Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| LV12200B (lv) * | 1997-07-03 | 1999-04-20 | Gunārs DUBURS | Antidiabētisks līdzeklis |
| CA2433288C (en) * | 2000-12-29 | 2006-06-13 | Pfizer Limited | Process for making amlodipine maleate |
| ATE472535T1 (de) * | 2001-02-14 | 2010-07-15 | Warner Lambert Co | Pyrimidinmatrixmetalloproteinaseinhibitoren |
| US6566359B1 (en) | 2002-05-20 | 2003-05-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as neuroprotective drugs |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
| DE2639257A1 (de) * | 1976-09-01 | 1978-03-02 | Bayer Ag | Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2658183A1 (de) * | 1976-12-22 | 1978-07-06 | Bayer Ag | In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4177278A (en) * | 1977-04-05 | 1979-12-04 | Bayer Aktiengesellschaft | 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use |
| DE2738153A1 (de) * | 1977-08-24 | 1979-03-08 | Bayer Ag | 2-pyridyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4307103A (en) * | 1978-09-08 | 1981-12-22 | Fujisawa Pharmaceutical Co., Ltd. | Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same |
| JPS5547656A (en) * | 1978-09-29 | 1980-04-04 | Dainippon Pharmaceut Co Ltd | 2-(2-substituted aminoethyl)-1,4-dihydropyridine derivative and its derivative |
| DE2844595A1 (de) * | 1978-10-13 | 1980-04-30 | Bayer Ag | Acylaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| CS228917B2 (en) * | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
| SE8105230L (sv) * | 1981-09-03 | 1983-03-04 | Haessle Ab | Nya dihydropyridiner |
| DE3269219D1 (en) * | 1981-11-17 | 1986-03-27 | Fisons Plc | Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals |
| DE3207982A1 (de) * | 1982-03-05 | 1983-09-08 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln |
| DK161312C (da) * | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
| WO1983003249A1 (en) * | 1982-03-17 | 1983-09-29 | Yoshitomi Pharmaceutical | 1,4-dihydropyridine-3,5-dicarboxylate derivatives |
| ATE20064T1 (de) * | 1982-07-22 | 1986-06-15 | Pfizer | Anti-ischaemische und antihypertensive dihydropyridin-derivate. |
| PH19166A (en) * | 1982-09-04 | 1986-01-16 | Pfizer | Dihydropyridined,pharmaceutical compositions and method of use |
| PT77842B (en) * | 1982-12-21 | 1986-05-05 | Pfizer | Process for preparing dihydropyridines |
| US4515799A (en) * | 1983-02-02 | 1985-05-07 | Pfizer Inc. | Dihydropyridine anti-ischaemic and antihypertensive agents |
| EP0125803A3 (en) * | 1983-04-27 | 1987-01-21 | FISONS plc | Pharmaceutically active dihydropyridines |
| US4568677A (en) * | 1983-07-23 | 1986-02-04 | Pfizer Inc. | 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents |
| GB8414518D0 (en) * | 1984-06-07 | 1984-07-11 | Pfizer Ltd | Therapeutic agents |
-
1985
- 1985-07-23 GR GR851819A patent/GR851819B/el unknown
- 1985-07-24 IE IE186085A patent/IE58706B1/en not_active IP Right Cessation
- 1985-07-26 AR AR85301104A patent/AR241417A1/es active
- 1985-07-29 IL IL75943A patent/IL75943A/xx not_active IP Right Cessation
- 1985-07-31 CA CA000487896A patent/CA1310011C/en not_active Expired - Fee Related
- 1985-08-01 NZ NZ212956A patent/NZ212956A/xx unknown
- 1985-08-02 AU AU45726/85A patent/AU587388B2/en not_active Ceased
- 1985-08-13 FI FI853103A patent/FI89166C/fi not_active IP Right Cessation
- 1985-08-14 PT PT80956A patent/PT80956B/pt not_active IP Right Cessation
- 1985-08-14 PH PH32635A patent/PH26049A/en unknown
- 1985-08-15 EP EP85305803A patent/EP0172029B1/en not_active Expired - Lifetime
- 1985-08-15 CZ CS855922A patent/CZ279473B6/cs unknown
- 1985-08-15 AT AT85305803T patent/ATE61055T1/de not_active IP Right Cessation
- 1985-08-15 GB GB08520485A patent/GB2168969B/en not_active Expired
- 1985-08-15 DE DE8585305803T patent/DE3581858D1/de not_active Expired - Fee Related
- 1985-08-16 HU HU853175A patent/HU194868B/hu not_active IP Right Cessation
- 1985-08-16 JP JP60180894A patent/JPH0680053B2/ja not_active Expired - Lifetime
- 1985-08-16 SU SU853940051A patent/SU1486059A3/ru active
- 1985-08-16 DK DK374185A patent/DK374185A/da unknown
- 1985-08-16 ES ES546189A patent/ES8604564A1/es not_active Expired
- 1985-08-16 KR KR1019850005902A patent/KR930000167B1/ko not_active IP Right Cessation
-
1986
- 1986-11-13 US US06/930,972 patent/US5068337A/en not_active Expired - Fee Related
-
1987
- 1987-05-18 MY MYPI87000676A patent/MY101736A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO850300L (no) | Fremgangsmaate for fremstilling av 3-imidazolylmetyl-tetrahydrokarbazolon-derivater | |
| ES555048A0 (es) | Procedimiento para la obtencion de derivados de azolilmetil-ciclopropilcarbinol sustituido | |
| ES548798A0 (es) | Procedimiento para la obtencion de derivados de 5-amino-4- hidroxivalerilo | |
| ES555815A0 (es) | Procedimiento de obtencion de derivados de mitomicina. | |
| ES540080A0 (es) | Procedimiento de preparar nuevos derivados de 1,3-dihidro-6-(1-hidroxi-2-dimetilaminometil-alil)-7-hidroxi-furo-(3,4-c)-piridina | |
| ES552827A0 (es) | Procedimiento de preparar derivados aminicos | |
| ES546189A0 (es) | Procedimiento de obtencion de derivados de 4-aril-1,4-dihi- dropiridinas | |
| ES556156A0 (es) | Procedimiento para la obtencion de derivados de la 13-beta-milbemicina | |
| ES557730A0 (es) | Procedimientopara la preparacion de derivados de 2-oxi-4h-3, 1-ebzoxazin-4-ona | |
| MX161397A (es) | Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona | |
| ES549116A0 (es) | Procedimiento para obtencion de derivados de flavolignano | |
| ES551481A0 (es) | Procedimiento de preparar derivados iminotiazolidinicos | |
| NO851550L (no) | Fremgangsmaate for fremstilling av imidazolderivater | |
| ES541265A0 (es) | Procedimiento para la obtencion de derivados de tiocianopi- rimidina | |
| ES545599A0 (es) | Procedimiento para la obtencion de derivados de ciclohexeno-na | |
| ES539074A0 (es) | Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos. | |
| ES546802A0 (es) | Procedimiento para preparar derivados de 7-oxo-4-tia-1-aza- biciclo(3,2,0)hept-2-eno | |
| ES546557A0 (es) | Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina | |
| NO161353C (no) | Fremgangsmaate for fremstilling av pastiller. | |
| ES547487A0 (es) | Procedimiento para la obtencion de derivados de la pirazolo-na | |
| ES546923A0 (es) | Procedimiento para la obtencion de derivados de salicilamida | |
| ES509419A0 (es) | Procedimiento de preparar nuevos derivados de aprovincaminol. | |
| ES547820A0 (es) | Procedimiento de preparacion de nuevos derivados nucleosidos. | |
| ES557309A0 (es) | Procedimiento mejorado de obtencion de derivados 5-fluouracilicos | |
| ES542485A0 (es) | Procedimiento de preparacion de derivados de bornano |